Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Bibliographic Details
Main Authors:	Minglu Liu, Tong Hu, Wenfeng Gou, Huajie Chang, Yanli Li, Yiliang Li, Daiying Zuo, Wenbin Hou, Shunchang Jiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Pharmacology
Subjects:	icaritin nasopharyngeal carcinoma ROS senescence network pharmacology
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1140018/full

Similar Items

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
by: Minglu Liu, et al.
Published: (2022-11-01)

Therapeutic Effect of Icaritin on Cerebral Ischemia-Reperfusion-Induced Senescence and Apoptosis in an Acute Ischemic Stroke Mouse Model
by: Cheng-Tien Wu, et al.
Published: (2022-09-01)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
by: Zhong Xue, et al.
Published: (2023-05-01)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
by: Yan-Bin Jin, et al.
Published: (2023-07-01)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
by: Yi Lu, et al.
Published: (2022-12-01)

Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects
by: Lifang Gao, et al.
Published: (2022-03-01)

Effect of icaritin on autophagy-related protein expression in TDP-43-transfected SH-SY5Y cells
by: Yanjun Zhou, et al.
Published: (2022-07-01)

Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition
by: Yi-Xuan Wang, et al.
Published: (2023-01-01)

Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis
by: Yu Lin, et al.
Published: (2023-04-01)

Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway
by: Lvfen Gao, et al.
Published: (2022-04-01)

Icaritin Promotes Myelination by Simultaneously Enhancing the Proliferation and Differentiation of Oligodendrocyte Precursor Cells
by: Feifei Yang, et al.
Published: (2023-08-01)

An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
by: Huating Zeng, et al.
Published: (2022-12-01)

Preparation, Characterization, and In Vivo Evaluation of Amorphous Icaritin Nanoparticles Prepared by a Reactive Precipitation Technique
by: Cheng Tang, et al.
Published: (2021-05-01)

Icaritin protects SH-SY5Y cells transfected with TDP-43 by alleviating mitochondrial damage and oxidative stress
by: Yongjian Zhou, et al.
Published: (2021-08-01)

The Synergy of Gene Targeting Drug Icaritin Soft Capsule with Immunomodulator and TACE Brings New Hope for Drug Combination in Patients with Advanced Liver Cancer: A Case Report and Literature Review
by: Tang X, et al.
Published: (2023-07-01)

Enhanced Oral Absorption of Icaritin by Using Mixed Polymeric Micelles Prepared with a Creative Acid-Base Shift Method
by: Cheng Tang, et al.
Published: (2021-06-01)

Bioactive Flavonoids Icaritin and Icariin Protect against Cerebral Ischemia–Reperfusion-Associated Apoptosis and Extracellular Matrix Accumulation in an Ischemic Stroke Mouse Model
by: Cheng-Tien Wu, et al.
Published: (2021-11-01)

Icaritin inhibits neuroinflammation in a rat cerebral ischemia model by regulating microglial polarization through the GPER–ERK–NF-κB signaling pathway
by: Zining Yu, et al.
Published: (2022-11-01)

UHPLC-ESI-QE-Orbitrap-MS based metabolomics reveals the antioxidant mechanism of icaritin on mice with cerebral ischemic reperfusion
by: Yunfeng Tang, et al.
Published: (2023-01-01)

Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
by: Hao Wu, et al.
Published: (2021-03-01)

Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresectable locally progressive pancreatic cancer and a literature review
by: Xiaolong Liu, et al.
Published: (2023-04-01)

Icaritin, an inhibitor of beta-site amyloid cleaving enzyme-1, inhibits secretion of amyloid precursor protein in APP-PS1-HEK293 cells by impeding the amyloidogenic pathway
by: Fei Feng, et al.
Published: (2019-12-01)

Magnesium dopped Calcium-Fluoride/Icaritin composite multi-layer coating functionalized 3D printed β-TCP scaffold induces sustained bone regeneration in a rabbit model
by: Peng Xue, et al.
Published: (2022-11-01)

Trifluoro-icaritin ameliorates spared nerve injury-induced neuropathic pain by inhibiting microglial activation through α7nAChR-mediated blockade of BDNF/TrkB/KCC2 signaling in the spinal cord of rats
by: Dandan Jia, et al.
Published: (2023-01-01)

TOM40 regulates the progression of nasopharyngeal carcinoma through ROS-mediated AKT/mTOR and p53 signaling
by: Hong Ran, et al.
Published: (2023-06-01)

Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma
by: Liping Wang, et al.
Published: (2022-12-01)

Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
by: Junjun Ling, et al.
Published: (2022-11-01)

Nasopharyngeal tuberculosis: a case report
by: Şenol Civelek, et al.
Published: (2008-03-01)

Epidemiology and Histopathology of Nasopharyngeal Neoplasms in Iran
by: Ali Safavi Naini, et al.
Published: (2023-01-01)

High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal carcinoma after radiotherapy
by: Xiaotian Xu, et al.
Published: (2023-01-01)

A Rare Case of Nasopharyngeal Teratoma
by: İbrahim Ömeroğlu, et al.
Published: (2020-11-01)

From Juvenile Nasopharyngeal Angiofibroma to Nasopharyngeal Carcinoma; A Rare Case Report of Nasopharyngeal Mass
by: Saleh Mohebbi, et al.
Published: (2019-10-01)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
by: Ki-Kwang Oh, et al.
Published: (2022-07-01)

A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials
by: Katherine Xu, et al.
Published: (2023-06-01)

Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis
by: Ahmad Adebayo Irekeola, et al.
Published: (2021-04-01)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01)

Association of circulating nutritional markers, diets, lifestyle, workplace and environmental exposures with nasopharyngeal carcinoma in two public hospitals in Malaysia
by: Ulaganathan, Vaidehi
Published: (2018)

Bioavailability Improvement Strategies for Icariin and Its Derivates: A Review
by: Róbert Szabó, et al.
Published: (2022-07-01)

Analysis of active components and molecular mechanism of action of Rubia cordifolia L. in the treatment of nasopharyngeal carcinoma based on network pharmacology and experimental verification
by: Ximing Yang, et al.
Published: (2023-06-01)

Effect of radiotherapy interruption on nasopharyngeal cancer
by: Fangrui Zhao, et al.
Published: (2023-04-01)